Sarepta Therapeutics Balance Sheet (2010-2026) | SRPT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	1,599.11M	2,115.87M	1,233.88M	868.57M	1,038.62M	966.78M	871.67M	851.93M	541.93M	428.43M	427.29M	383.62M	197.85M	844.19M	240.87M	153.27M	404.56M	801.28M	216.82M	577.04M
Short-term Investments (Quarter)			779.50M	1,059.50M	1,033.90M	1,022.60M	1,010.43M	1,008.79M	1,191.61M	1,247.82M	963.45M	1,076.85M	44.62M	251.78M	281.89M	289.54M	237.92M	138.37M	188.74M	217.34M
Cash & Current Investments (Quarter)	1,599.11M	2,115.87M	2,013.38M	1,928.07M	2,072.52M	1,989.37M	1,882.10M	1,860.71M	1,733.54M	1,676.25M	1,390.74M	1,460.47M	242.48M	1,095.97M	522.76M	442.81M	642.47M	939.65M	405.56M	794.38M
Receivables - Net (Quarter)	149.32M	152.99M	178.20M	203.90M	201.51M	214.60M	223.84M	236.81M	318.90M	400.33M	378.81M	360.00M	434.52M	601.99M	659.40M	527.30M	395.74M	398.20M	394.82M	376.82M
Receivables - Other (Quarter)	29.10M	0.01M	17.70M	26.40M	21.90M	3.31M	62.00M	28.60M	35.40M	29.80M	30.10M	19.90M	66.40M	34.60M	55.20M	73.30M	128.70M	104.10M	136.40M	45.00M
Receivables (Quarter)	178.42M	153.00M	195.90M	230.30M	223.41M	217.91M	285.84M	265.41M	354.30M	430.13M	408.91M	379.90M	500.92M	636.59M	714.60M	600.60M	524.44M	502.30M	531.22M	421.82M
Raw Materials (Quarter)	40.16M	58.82M	245.27M	253.20M	57.98M	59.18M	84.47M	243.06M	114.62M	133.96M	150.01M	167.20M	208.32M	280.05M	298.98M	314.85M	325.54M	141.28M	136.96M	127.78M
Work In Process (Quarter)						269.19M				318.46M		470.38M	482.17M	610.69M	762.23M	802.87M	885.42M	892.69M	981.04M	946.65M
Finished Goods (Quarter)	26.83M	26.72M	33.88M	35.50M	49.26M	38.15M	42.69M	47.61M	47.24M	61.81M	39.50M	52.90M	77.98M	47.21M	61.37M	70.98M	64.80M	65.32M	57.98M	56.17M
Inventory (Quarter)	288.47M	186.21M	199.00M	208.09M	221.19M	203.97M	202.68M	226.88M	244.01M	322.86M	373.53M	485.80M	565.92M	749.96M	941.43M	994.04M	1,077.17M	914.74M	1,001.11M	904.27M
Prepaid Assets (Quarter)	1.03M	149.03M	140.33M	3.28M	130.74M	149.89M	179.77M	3.14M	154.44M	3.35M	1.95M	74.74M	165.48M	90.46M	105.48M	127.59M	2.41M	171.86M	2.22M	105.78M
Current Assets (Quarter)	2,185.31M	2,604.10M	2,530.95M	2,469.30M	2,625.93M	2,557.86M	2,488.38M	2,472.61M	2,450.85M	2,579.33M	2,464.86M	2,683.64M	2,685.37M	3,073.46M	2,432.53M	2,656.99M	2,722.31M	2,537.94M	2,309.88M	2,223.82M
Non-Current Assets
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)	199.25M	191.16M	187.25M	183.29M	181.00M	180.04M	182.86M	188.87M	212.37M	227.15M	249.30M	276.20M	305.79M	340.34M	360.59M	371.86M	358.94M	345.12M	336.24M	325.99M
Long-Term Investments (Quarter)	9.30M	34.89M	9.65M	33.23M	33.24M	31.32M	31.00M	19.02M	7.50M	6.53M	33.92M	7.61M	4.72M	133.16M	109.12M	324.10M	8.16M	1.05M	270.70M	362.70M
Intangibles (Quarter)	14.20M	14.24M	13.33M	13.06M	13.06M	7.58M	7.20M	18.02M	19.50M	10.00M	28.93M	28.25M	27.57M	26.89M	26.20M	30.52M	29.68M	28.95M	31.38M	30.61M
Goodwill & Intangibles (Quarter)	14.20M	14.24M	13.33M	13.06M	13.06M	7.58M	7.20M	18.02M	19.50M	10.00M	28.93M	28.25M	27.57M	26.89M	26.20M	30.52M	29.68M	28.95M	31.38M	30.61M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	3.47M	3.86M	278.65M	3.54M	4.22M	2.15M	162.39M	2.20M	2.22M	136.77M	15.58M	3.14M	15.58M	1.14M	15.58M	83.14M	73.38M	5.19M	4.12M	146.15M
Non-Current Assets (Quarter)	476.91M	543.88M	525.21M	527.55M	530.22M	570.50M	571.41M	653.28M	658.86M	685.25M	759.52M	740.62M	914.57M	889.71M	1,032.85M	1,022.83M	771.13M	811.76M	869.06M	964.69M
Assets (Quarter)	2,662.22M	3,147.97M	3,056.15M	2,996.85M	3,156.15M	3,128.37M	3,059.79M	3,125.89M	3,109.71M	3,264.58M	3,224.39M	3,424.26M	3,599.93M	3,963.17M	3,465.39M	3,679.81M	3,493.44M	3,349.70M	3,178.93M	3,188.51M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	44.16M	76.74M	54.01M	56.21M	118.46M	95.88M	106.71M	109.80M	87.95M	164.92M	91.54M	107.42M	118.77M	214.44M	156.10M	136.70M	94.02M	280.84M	70.38M	50.98M
Notes Payables (Quarter)
Payables (Quarter)	44.16M	76.74M	54.01M	56.21M	118.46M	95.88M	106.71M	109.80M	87.95M	164.92M	91.54M	107.42M	118.77M	214.44M	156.10M	136.70M	94.02M	280.84M	70.38M	50.98M
Accumulated Expenses (Quarter)	29.73M	1.04M	3.18M	383.70M	42.69M	4.96M	345.55M	44.91M	51.14M	78.73M	32.11M	50.02M	57.11M	373.51M	35.30M	377.40M	3.48M	58.61M	5.36M	325.23M
Other Accumulated Expenses (Quarter)	6.04M	15.05M	12.98M	16.42M	4.34M	5.31M	8.38M	8.58M	10.50M	12.07M	11.21M	17.13M	5.39M	13.47M	15.66M	5.93M	10.17M	6.96M	4.63M	16.56M
Short term Debt (Quarter)										105.48M	105.59M	91.50M	91.59M				36.00M
Current Leases (Quarter)						15.49M				17.84M
Current Taxes (Quarter)		0.22M			4.09M	12.52M	16.09M	20.82M	24.68M	13.77M	18.29M			17.39M	79.86M	18.73M	9.09M	4.75M	13.79M	9.31M
Current Deferred Revenue (Quarter)	89.24M	89.24M	89.24M	89.24M	89.24M	89.24M	67.24M	44.99M	22.49M	50.42M	112.00M	122.04M	127.00M	130.26M	44.86M	395.43M	485.45M	443.40M	116.04M	110.13M
Total Current Liabilities (Quarter)	373.44M	452.73M	454.96M	545.57M	602.92M	619.60M	536.88M	498.65M	450.74M	653.66M	608.71M	688.49M	699.49M	731.68M	605.59M	919.95M	921.42M	1,095.29M	499.16M	502.91M
Non-Current Liabilities
Non-Current Debt (Quarter)	1,094.91M	563.67M	1,098.85M	1,100.87M	1,542.77M	1,544.29M	1,234.28M	1,235.52M	1,236.76M	1,238.00M	1,239.25M	1,226.32M	1,135.96M	1,137.12M	1,138.29M	1,139.46M	1,035.15M	828.97M	838.16M	847.62M
Non-Current Deffered Revenue (Quarter)	596.74M	574.24M	552.24M	529.99M	507.49M	485.00M	485.00M	485.00M	485.00M	437.00M	325.00M	325.00M	325.00M	325.00M	325.00M			83.91M	136.35M	110.13M
Operating Leases (Quarter)	63.43M	41.51M	38.62M	39.37M	35.23M	57.58M	53.93M	129.17M	134.75M	140.97M	140.10M	143.60M	170.01M	192.47M	205.46M	214.42M	215.04M	199.38M	198.50M	198.23M
Other Non-Current Liabilities (Quarter)	43.60M	43.60M	11.00M	11.00M	36.90M	36.90M	36.90M	36.10M	38.10M	38.10M	48.20M	48.20M	47.40M	47.40M	47.40M	47.40M	36.30M	1.53M	1.65M	1.82M
Total Non-Current Liabilities (Quarter)	2,149.09M	2,176.36M	2,188.27M	2,259.40M	2,688.41M	2,706.52M	2,310.14M	2,348.38M	2,307.25M	2,367.14M	2,214.99M	2,298.99M	2,331.46M	2,388.03M	2,275.26M	2,275.03M	2,137.02M	2,207.55M	1,672.18M	1,658.89M
Total Liabilities (Quarter)	2,192.69M	2,219.97M	2,199.27M	2,270.40M	2,725.31M	2,743.42M	2,347.04M	2,384.48M	2,345.35M	2,405.24M	2,263.19M	2,347.19M	2,378.86M	2,435.43M	2,322.66M	2,322.43M	2,173.32M	2,209.08M	1,673.83M	1,660.71M
Shareholder's Equity
Total Debt (Quarter)	1,094.91M	563.67M	1,098.85M	1,100.87M	1,542.77M	1,544.29M	1,234.28M	1,235.52M	1,236.76M	1,343.48M	1,344.83M	1,317.82M	1,227.56M	1,137.12M	1,138.29M	1,139.46M	1,071.15M	828.97M	838.16M	847.62M
Common Equity (Quarter)	469.53M	928.01M	856.89M	726.46M	430.84M	384.95M	712.75M	741.41M	764.36M	859.34M	961.19M	1,077.07M	1,221.07M	1,527.74M	1,142.72M	1,357.38M	1,320.12M	1,140.62M	1,505.10M	1,527.80M
Liabilities and Shareholders Equity (Quarter)	2,662.22M	3,147.97M	3,056.15M	2,996.85M	3,156.15M	3,128.37M	3,059.79M	3,125.89M	3,109.71M	3,264.58M	3,224.39M	3,424.26M	3,599.93M	3,963.17M	3,465.39M	3,679.81M	3,493.44M	3,349.70M	3,178.93M	3,188.51M
Treasury Shares (Quarter)		1.32M				1.83M				2.24M						-0.65M	0.65M	0.65M	0.66M	0.66M
Retained Earnings (Quarter)	-3084.77M	-3206.75M	-0.31M	-2.48M	-3.21M	-3910.24M	-4426.99M	-1.05M	-4491.87M	0.92M	-0.69M	-4403.63M	-4370.02M	-4210.97M	0.03M	-0.05M	0.22M	-4876.98M	-0.12M	-4550.91M

Research Tools

Datasets

Plans

Developers

Sarepta Therapeutics Balance Sheet (2010-2026) | SRPT

Research Tools

Datasets

Plans

Developers

Sarepta Therapeutics Balance Sheet (2010-2026) | SRPT

Create an account

Sign In

Reset Password